| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 33,203 | 33,547 | 39,751 | 58,344 | | Cost of Revenue | 26,185 | 25,952 | 31,084 | 44,375 | | | Gross Profit | 7,018 | 7,595 | 8,667 | 13,969 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,222 | 7,803 | 7,513 | 10,162 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 139 | 166 | 313 | (636) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (343) | (374) | 841 | 4,443 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (375) | (261) | 89 | 920 | | Earnings Before Interest And Taxes | (1,753) | (635) | 930 | 5,363 | | Interest Expense | (709) | 347 | 362 | 433 | | Income Before Tax | (1,044) | (982) | 568 | 4,930 | | Income Tax Expense | (366) | (343) | 199 | 1,570 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (678) | (639) | 369 | 3,360 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (678) | (639) | 369 | 3,360 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($678) | ($639) | $369 | $3,360 |
|
0.31% Nasdaq 
0.05%
Income Statement
